Jean-Marie Eveillard - First Eagle Investment Management
Holding/activity history for Pacira BioSciences, Inc. (PCRX)
← All PCRX superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2024 Q1 | 0 | 0.00 | Sell 100.00% | 0.01 | $27.37–35.95 · VW $30.79i | SEC | |
| 2023 Q4 | 103,081 | 0.01 | Reduce 50.35% | 0.01 | $25.93–34.52 · VW $29.65i | $3,477,953 | SEC |
| 2023 Q3 | 207,632 | 0.02 | Reduce 15.00% | <0.01 | $30.43–40.45 · VW $35.66i | $6,370,150 | SEC |
| 2023 Q2 | 244,272 | 0.03 | Add 38.46% | <0.01 | $35.47–48.60 · VW $41.44i | $9,787,979 | SEC |
| 2023 Q1 | 176,425 | 0.02 | Add 112.53% | 0.01 | $35.35–44.53 · VW $40.40i | $7,199,905 | SEC |
| 2022 Q4 | 83,013 | 0.01 | Add 5.71% | <0.01 | $37.69–58.10 · VW $47.08i | $3,205,132 | SEC |
| 2022 Q3 | 78,531 | 0.01 | Add 12.47% | <0.01 | $50.43–59.33 · VW $54.68i | $4,177,000 | SEC |
| 2022 Q2 | 69,825 | 0.01 | Add 46.32% | <0.01 | $50.14–82.16 · VW $66.85i | $4,071,000 | SEC |
| 2022 Q1 | 47,721 | 0.01 | Add 92.18% | <0.01 | $58.98–77.42 · VW $67.48i | $3,642,000 | SEC |
| 2021 Q4 | 24,832 | <0.01 | Buy | <0.01 | $45.05–63.09 · VW $54.66i | $1,494,000 | SEC |
Price snapshot:
Current price$25.54
52-week low$18.80
52-week high$27.64